Patent 11033625 was granted and assigned to Allergan, Inc. on June, 2021 by the United States Patent and Trademark Office.
Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.